Cancer Conquered As Russia Unveils Free Cancer Vaccine For Treatment Set For 2025
Russia has unveiled an mRNA-based vaccine designed specifically for cancer treatment, PulseNets has learned from Indian Business Today.
This revolutionary therapy is scheduled for rollout in early 2025 and will be offered to citizens free of charge, as reported by state-controlled media.
The personalized vaccine is crafted using genetic material extracted directly from the patient’s tumor and is estimated to cost the Russian government around 300,000 rubles (approximately USD 2,869) per dose.
Speaking to PulseNets, Andrey Kaprin, the head of the Radiology Medical Research Centre under the Ministry of Health, explained, “Our objective is to treat those already affected by cancer, rather than merely preventing tumor development.”
Alexander Gintsburg, director of the Gamaleya National Research Centre for Epidemiology and Microbiology, elaborated on the intricate process involved in the vaccine’s creation.
In an interview with TASS, he stated, “Producing personalized vaccines currently requires considerable time because the generation of custom mRNA is akin to advanced mathematical modeling. We are collaborating with the Ivannikov Institute to incorporate AI, specifically neural network computing, which will significantly reduce the time needed for these calculations to just 30 to 60 minutes.”
This innovative vaccine works by training the immune system to detect and destroy cancer cells. By using components derived from the patient’s tumor, it helps the body identify specific proteins, known as antigens, present on the surface of cancer cells. Once these antigens are introduced, the immune system generates antibodies that specifically target and eliminate cancer cells.
According to figures shared with PulseNets, cancer cases in Russia are on the rise, with over 635,000 new diagnoses recorded in 2022 alone. The most common forms of cancer include colon, breast, and lung cancers.
This Russian breakthrough aligns with global efforts in personalized cancer treatment. In the United States, researchers at the University of Florida have been testing a customized vaccine for glioblastoma, an aggressive type of brain cancer. Early findings, as learnt by PulseNets, suggest a strong immune response within just two days of administration.
Also Read: Russia Expands Military Ties with Burkina Faso as Wagner Mercenaries are Killed in Mali
Similarly, in the UK, scientists are conducting trials on a tailored vaccine for melanoma, the deadliest form of skin cancer. Reports indicate that initial results show improved survival rates.
This personalized approach to cancer therapy could redefine the future of oncology worldwide.
